Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.8%

1 terminated out of 21 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

31%

4 of 13 completed with results

Key Signals

4 with results93% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (7)
Early P 1 (1)
P 1 (1)
P 2 (1)
P 4 (4)

Trial Status

Completed13
Unknown5
Enrolling By Invitation1
Recruiting1
Terminated1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07468513Phase 4Recruiting

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

NCT05879224Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

NCT05874271Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea

NCT03655223Enrolling By Invitation

Early Check: Expanded Screening in Newborns

NCT03529396Phase 2Completed

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

NCT04073953Phase 1CompletedPrimary

Primaquine Enantiomers in G6PD Deficient Human Volunteers

NCT01931644Completed

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

NCT05753150Completed

Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand

NCT05096702Unknown

Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil

NCT05571748Not ApplicableUnknownPrimary

Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency

NCT04010695Not ApplicableCompletedPrimary

Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

NCT05026489Unknown

G6PD Deficiency in Infarction Patients in Shaanxi Province

NCT04088513Phase 4UnknownPrimary

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

NCT02937376Early Phase 1UnknownPrimary

Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise

NCT03337152Phase 4Terminated

Assessing a Risk Model for G6PD Deficiency

NCT04033640Not ApplicableCompletedPrimary

Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Brazil

NCT04054661Not ApplicableCompletedPrimary

Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood

NCT04146246Completed

Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates

NCT04081272CompletedPrimary

Effect of G6PD Deficiency on Red Blood Cell Storage

NCT02937363Not ApplicableCompletedPrimary

Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise

Scroll to load more

Research Network

Activity Timeline